Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Ohr Pharmaceutical Given “Strong-Buy” Rating at Vista Partners (OHRP)
Ohr Pharmaceutical Given “Strong-Buy” Rating at Vista Partners (OHRP)
Ohr Pharmaceutical Given “Strong-Buy” Rating at Vista Partners (OHRP)
Submitted by
admin
on October 21, 2012 - 11:10am
Source:
Zolmax
News Tags:
Ohr Pharmaceutical
macular degeneration
Squalamine Eye Drops
OHR/AVR 118
Cancer Cachexia
Headline:
Ohr Pharmaceutical Given “Strong-Buy” Rating at Vista Partners (OHRP)
Do Not Allow Advertisers to Use My Personal information
